RBC OraSure at sector perform

OraSure Technologies, Inc. was rated at sector perform, speculative risk, by RBC Capital Markets analyst William R. Quirk ahead of the company's second-quarter 2006 results. RBC is modeling a 6.1% revenue decline in the quarter to $16.4 million, slightly above consensus, due to anticipated sluggish Insurance Risk Assessment and Infectious Disease Testing growth. A channel check of on wart removal products found mixed results, with the majority of pharmacies recommending salicilic acid products as a first line of defense against warts. However, freezing products were noted as a quicker, but more expensive, solution. According to the analyst, all stores were stocked with Freeze Off and none noted any promotional activity. Shares of the Bethlehem, Pa.-based medical device company were down 7 cents, or 0.75%, at $9.30, on volume of 217,786 shares versus the three-month running average of 451,920 shares. (Nasdaq: OSUR)

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.